Overall rank by patents
#32,074
Across all tracked assignees
USPTO PatentsView assignee record - 8 granted patents across 11 technology areas, active 2015–2019. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C03C (CHEMICAL COMPOSITION OF GLASSES, GLAZES OR VITREOUS ENAMELS; SURFACE TREATMENT OF GLASS; SURFACE TREATMENT OF FIBRES OR FILAMENTS MADE FROM GLASS, MINERALS OR SLAGS; JOINING GLASS TO GLASS OR OTHER MA).
The verdict
Imerys holds 8 US patents across 11 technology areas, rank #32,074 of 50,000 tracked assignees.
Imerys Filtration Minerals, Inc. has been granted 8 US utility patents between 2015 and 2019, placing Imerys Filtration Minerals, Inc. at rank #32,074 across all assignees tracked by PlainPatent. This portfolio spans 11 distinct Cooperative Patent Classification (CPC) subclasses, averaging 17.6 claims per patent with primary concentration in C03C (CHEMICAL COMPOSITION OF GLASSES, GLAZES OR VITREOUS ENAMELS; SURFACE TREATMENT OF GLASS; SURFACE TREATMENT OF FIBRES OR FILAMENTS MADE FROM GLASS, MINERALS OR SLAGS; JOINING GLASS TO GLASS OR OTHER MA). As a US Corporation, Imerys Filtration Minerals, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Imerys sits between Idera, Inc. (8 patents, rank #32,070) and Imperative Chemical Partners Inc. (8 patents, rank #32,078) - the closest US assignees by grant volume. The composite Innovation Score of 29.9/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 0 grants, compared with 8 in the 2015–2019 window, a -100% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Imerys Filtration Minerals, Inc.'s 17.6 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 11 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Imerys Filtration Minerals, Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Idera, Inc.
8 patents
Igistec Co., Ltd.
8 patents
ImaTx, Inc.
8 patents
ImageWare Systems Inc.
8 patents
Immatics US, INC.
8 patents
ImmuNext, Inc.
8 patents
Immunomic Therapeutics, Inc.
8 patents
Imperative Chemical Partners Inc.
8 patents
Imerys Filtration Minerals, Inc.
8 patents
What this shows Imerys holds 8 patents at rank #32,074, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #32,074 in granted patent volume.
Other assignees with the most granted patents in Imerys's primary technology class.
Imerys's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
30 Top 68% higher than 32% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 1 | 12.5% |
| 2016 | 1 | 12.5% |
| 2017 | 2 | 25.0% |
| 2018 | 3 | 37.5% |
| 2019 | 1 | 12.5% |
Top 11 of 11 technology areas
Overall rank by patents
#32,074
Across all tracked assignees
29.9 out of 100
How to use this portfolio
Imerys's 8 grants land it in the top 68% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.